Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Rao, Priya"'
Autor:
Msaouel P; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Goswami S; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Thall PF; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wang X; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yuan Y; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jonasch E; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gao J; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Campbell MT; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shah AY; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Corn PG; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tam AL; Department of Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ahrar K; Department of Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rao P; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sircar K; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Cohen L; Department of Palliative, Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Basu S; The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Duan F; The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jindal S; The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang Y; The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chen H; The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yadav SS; The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shazer R; Mirati Therapeutics Inc., San Diego, CA 92121, USA., Der-Torossian H; Mirati Therapeutics Inc., San Diego, CA 92121, USA., Allison JP; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Sharma P; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tannir NM; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 Apr 20; Vol. 14 (641), pp. eabm6420. Date of Electronic Publication: 2022 Apr 20.